Panacea Biotec Ltd. benchmarking: Perfomance to industry peers

Financial

	Panacea Biotec	Indoco Remedies	Novartis
Operational Metrics
Pharmaceuticals
Number of ANDA's Filed in USA	6.0 .	54.0 .	n/a
R&D as a % of Total Sales	9.86 %	5.7 %	n/a
Financials
5 yr Average ROE	36.5 %	8.94 %	8.0 %
5yr average Equity Multiplier	0.36	1.9	2.72
5yr Average Asset Turnover Ratio	0.41	0.88	0.18
5yr Avg Net Profit Margin	26.1 %	5.41 %	17.12 %
Price to Book	2.89	2.46	2.61
P/E	0.0	0.0	18.99
5yr Avg Cash Conversion Cycle	-170.26 Days	35.3 Days	-23.33 Days
Inventory Days	120.03 Days	70.6 Days	44.27 Days
Days Receivable	42.2 Days	83.16 Days	38.18 Days
Days Payable	325.14 Days	111.01 Days	124.28 Days
5yr Average Interest Coverage Ratio	2.7	7.53	65.43
5yr Avg ROCE	-2.79 %	13.6 %	5.91 %
5yr Avg Operating Profit Margin	-3.85 %	14.97 %	15.15 %
5 yr average Debt to Equity	-0.69	0.49	0.0
5yr CAGR Net Profit	-43.68 %	n/a	37.01 %
5yr Average Return on Assets	9.32 %	5.31 %	3.13 %
Shareholdings
Promoter Holding	72.48 %	58.9 %	70.68 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	-1.11 %	0.21 %	0.0
Change in Mutual Fund Holding (3 Yrs)	0.0	0.31 %	0.0

Business

	Panacea Biotec	Indoco Remedies	Novartis
Therapeutic Area Wise Break-Up - Domestic	Therapeutic Area Wise Break-Up - Domestic Anti - Diabetes 43.91 Gastro Intestinal 13.47 Pain Management 12.87 Anti-Neoplastics 8.18 Vitamins / Minerals / Nutrients 6.09 Respiratory Systems 5.39 Vaccines 5.39 Blood Related 2.99 Hormones 0.6 Cardiac 0 Urological 0 Dermatology 0 Gynaecology 0 Pain / Analgesics 0 Ophthal / Otologicals 0 Vitamins / Minerals / Nutrients 0 Anti-Infectives 0 Stomatologicals 0 Others 1.11	Therapeutic Area Wise Break-Up - Domestic Vitamins / Minerals / Nutrients 9.07 Ophthalmology 5.88 Stomatologicals 13.47 Dermatology 5.05 Vaccines 0 Cardiac Science 3.12 Gastro Intestinal 18.13 Hormones 0 Urology 8.44 Pain Management 0 Anti-Infective 15.18 Respiratory Systems 0 Pain Management 3.41 Gynecology 1.17 Anti-Neoplastics 0 Blood Related 0 Anti - Diabetes 0 Others 17.08	-
Product Wise Break-Up	Product Wise Break-Up Vaccines 67.34 Formulations 32.66 Research and Development 0 CRO, Analytical Services 0 API 0 Formulation 0 0	Product Wise Break-Up Formulations 0 Research and Development 0 Formulations 90.0 Active Pharmaceutical Ingredient (API) 9.0 0 CRO, Analytical Services 1.0 Vaccines 0	Product Wise Break-Up Formulations 0 Research and Development 0 Formulation 0 API 0 Wholesale of pharmaceuticals and medical goods 100.0 CRO, Analytical Services 0 Vaccines 0
Location Wise Break-Up	Location Wise Break-Up Rest of the World 86.09 India 13.91	Location Wise Break-Up India 64.75 Rest of the World 35.25	Location Wise Break-Up India 100.0 Rest of the World 0
Operating Profit Break-Up	Operating Profit Break-Up Others 100	-	-
Capex	Capex Vaccines 69.46 Formulations 30.54 Real estate 0	-	-
Brand Wise Break-Up	Brand Wise Break-Up PanGraf 21.0 Glizid Family 19.0 Sitcom Family 10.0 Mycept & Mycept 5.0 Livoluk Family 4.0 Panimun Bioral 4.0 PacliAll 1.0 Thank OD Family 0 Nimulid Family 0 Others 36.0	-	-
Asset Break-Up	Asset Break-Up Vaccines 68.55 Formulations 31.45 Real Estate 0	-	-

Panacea Biotec Ltd.

Panacea Biotec Ltd.

Financial

Business

SIGN UP FOR FREE